Bionano to Present at the Canaccord Genuity 44th Annual Growth Conference
Bionano Genomics (Nasdaq: BNGO) has announced that its CEO, Erik Holmlin, will be presenting at the Canaccord Genuity 44th Annual Growth Conference on August 13, 2024. The presentation is scheduled for 3:30 p.m. to 3:55 p.m. ET.
Interested parties can register for the webcast through a provided link. For those unable to attend live, a replay of the session will be available on the Bionano website at https://ir.bionano.com/ for at least 30 days following the conference.
This presentation offers an opportunity for investors and analysts to gain insights into Bionano's growth strategies and recent developments in the genomics field.
Bionano Genomics (Nasdaq: BNGO) ha annunciato che il suo CEO, Erik Holmlin, presenterà al Canaccord Genuity 44º Annual Growth Conference il 13 agosto 2024. La presentazione è programmata per le 15:30 - 15:55 ET.
Le parti interessate possono registrarsi per il webcast tramite un link fornito. Per coloro che non possono partecipare dal vivo, una registrazione della sessione sarà disponibile sul sito web di Bionano all'indirizzo https://ir.bionano.com/ per almeno 30 giorni dopo la conferenza.
Questa presentazione rappresenta un'opportunità per investitori e analisti di acquisire informazioni sulle strategie di crescita di Bionano e sugli sviluppi recenti nel campo della genomica.
Bionano Genomics (Nasdaq: BNGO) ha anunciado que su CEO, Erik Holmlin, estará presentando en la Canaccord Genuity 44ª Conferencia Anual de Crecimiento el 13 de agosto de 2024. La presentación está programada para 3:30 p.m. a 3:55 p.m. ET.
Las partes interesadas pueden registrarse para el webcast a través de un enlace proporcionado. Para aquellos que no puedan asistir en vivo, se ofrecerá una repetición de la sesión en el sitio web de Bionano en https://ir.bionano.com/ durante al menos 30 días después de la conferencia.
Esta presentación ofrece una oportunidad para que los inversores y analistas obtengan información sobre las estrategias de crecimiento de Bionano y los desarrollos recientes en el campo de la genómica.
Bionano Genomics (Nasdaq: BNGO)는 Erik Holmlin CEO가 Canaccord Genuity 제44회 연례 성장 컨퍼런스에서 발표할 것이라고 발표했습니다. 발표는 2024년 8월 13일에 오후 3시 30분부터 3시 55분 ET로 예정되어 있습니다.
관심 있는 분들은 제공된 링크를 통해 웹캐스트에 등록할 수 있습니다. 실시간 참석이 어려운 분들을 위해서는 컨퍼런스 이후 최소 30일 동안 Bionano 웹사이트 https://ir.bionano.com/에서 세션 재생이 가능합니다.
이번 발표는 투자자 및 분석가들에게 Bionano의 성장 전략과 최근 유전체학 분야의 발전에 대한 통찰력을 얻을 수 있는 기회를 제공합니다.
Bionano Genomics (Nasdaq: BNGO) a annoncé que son PDG, Erik Holmlin, présentera lors de la 44ème Conférence Annuelle de Croissance de Canaccord Genuity le 13 août 2024. La présentation est prévue de 15h30 à 15h55 ET.
Les parties intéressées peuvent s'inscrire pour le webcast via un lien fourni. Pour ceux qui ne peuvent pas assister en direct, un replay de la session sera disponible sur le site web de Bionano à l'adresse https://ir.bionano.com/ pendant au moins 30 jours après la conférence.
Cette présentation offre une opportunité pour les investisseurs et les analystes d'obtenir des informations sur les stratégies de croissance de Bionano et les développements récents dans le domaine de la génomique.
Bionano Genomics (Nasdaq: BNGO) hat angekündigt, dass CEO Erik Holmlin auf der Canaccord Genuity 44. jährlichen Wachstums konferenz am 13. August 2024 präsentieren wird. Die Präsentation ist von 15:30 bis 15:55 Uhr ET geplant.
Interessierte Parteien können sich über einen bereitgestellten Link für das Webcast registrieren. Für diejenigen, die nicht live teilnehmen können, wird eine Wiederholung der Sitzung mindestens 30 Tage nach der Konferenz auf der Bionano-Website unter https://ir.bionano.com/ verfügbar sein.
Diese Präsentation bietet Investoren und Analysten die Möglichkeit, Einblicke in die Wachstumsstrategien von Bionano und die neuesten Entwicklungen im Bereich der Genomik zu erhalten.
- None.
- None.
SAN DIEGO, July 31, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano’s president and chief executive officer, will present at the Canaccord Genuity 44th Annual Growth Conference on August 13, 2024.
Conference & Webcast Details
| Date: | August 13, 2024 |
| Time: | 3:30 p.m. to 3:55 p.m. ET |
| Presenter: | Erik Holmlin, PhD, CEO of Bionano |
| Webcast: | Link to Register |
A replay / recording of the session will be available following the conference through the Bionano website at https://ir.bionano.com/ for at least 30 days.
About Bionano
Bionano is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company’s mission is to transform the way the world sees the genome through OGM solutions, diagnostic services and software. The Company offers OGM solutions for applications across basic, translational and clinical research. The Company also offers an industry-leading, platform-agnostic genome analysis software solution and nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. Through its Lineagen, Inc. d/b/a Bionano Laboratories business, the Company also offers OGM-based diagnostic testing services.
For more information, visit http://www.bionano.com or www.bionanolaboratories.com.
Bionano’s OGM products are for research use only and not for use in diagnostic procedures.
CONTACTS
Company Contact:
Erik Holmlin, CEO
Bionano Genomics, Inc.
+1 (858) 888-7610
eholmlin@bionano.com
Investor Relations:
David Holmes
Gilmartin Group
+1 (858) 888-7625
IR@bionano.com
FAQ
When is Bionano Genomics (BNGO) presenting at the Canaccord Genuity Growth Conference?
Who will be presenting for Bionano Genomics (BNGO) at the Canaccord Genuity conference?
How can I watch Bionano Genomics' (BNGO) presentation at the Canaccord Genuity conference?
What is the significance of Bionano Genomics (BNGO) presenting at the Canaccord Genuity conference?
